Neuromodulation for functional bowel disorders

    Research output: Contribution to journalArticleAcademicpeer-review

    9 Citations (Scopus)

    Abstract

    In patients with functional bowel disorders not responding to maximal medical treatment, bowel lavage or biofeedback therapy, can nowadays be treated by sacral nerve neuromodulation (SNM). SNM therapy has evolved as a treatment for faecal incontinence and constipation. The exact working mechanism remains unknown. It is known that SNM therapy causes direct stimulation of the anal sphincter and causes changes in rectal sensation and several central nervous system areas. The advantage of SNM therapy is the ability to do a minimally invasive temporary screening phase to assess permanent stimulation outcome. Ideal candidates for SNM therapy are not known. Several studies have described positive and negative predictive factors, but the temporary screening remains the instrument of choice. Clinical results are good and as the technique is developing, fewer complications occur. New indications for SNM include constipation and anorectal or pelvic pain.
    Original languageEnglish
    Pages (from-to)545-53
    JournalBest Practice & Research in Clinical Gastroenterology
    Volume23
    Issue number4
    DOIs
    Publication statusPublished - 1 Jan 2009

    Cite this

    @article{67975e76a8c54ad49eeea1b5045bde65,
    title = "Neuromodulation for functional bowel disorders",
    abstract = "In patients with functional bowel disorders not responding to maximal medical treatment, bowel lavage or biofeedback therapy, can nowadays be treated by sacral nerve neuromodulation (SNM). SNM therapy has evolved as a treatment for faecal incontinence and constipation. The exact working mechanism remains unknown. It is known that SNM therapy causes direct stimulation of the anal sphincter and causes changes in rectal sensation and several central nervous system areas. The advantage of SNM therapy is the ability to do a minimally invasive temporary screening phase to assess permanent stimulation outcome. Ideal candidates for SNM therapy are not known. Several studies have described positive and negative predictive factors, but the temporary screening remains the instrument of choice. Clinical results are good and as the technique is developing, fewer complications occur. New indications for SNM include constipation and anorectal or pelvic pain.",
    author = "B. Govaert and {van Gemert}, W.G. and C.G. Baeten",
    year = "2009",
    month = "1",
    day = "1",
    doi = "10.1016/j.bpg.2009.04.009",
    language = "English",
    volume = "23",
    pages = "545--53",
    journal = "Best Practice & Research in Clinical Gastroenterology",
    issn = "1521-6918",
    publisher = "ELSEVIER SCI LTD",
    number = "4",

    }

    Neuromodulation for functional bowel disorders. / Govaert, B.; van Gemert, W.G.; Baeten, C.G.

    In: Best Practice & Research in Clinical Gastroenterology, Vol. 23, No. 4, 01.01.2009, p. 545-53.

    Research output: Contribution to journalArticleAcademicpeer-review

    TY - JOUR

    T1 - Neuromodulation for functional bowel disorders

    AU - Govaert, B.

    AU - van Gemert, W.G.

    AU - Baeten, C.G.

    PY - 2009/1/1

    Y1 - 2009/1/1

    N2 - In patients with functional bowel disorders not responding to maximal medical treatment, bowel lavage or biofeedback therapy, can nowadays be treated by sacral nerve neuromodulation (SNM). SNM therapy has evolved as a treatment for faecal incontinence and constipation. The exact working mechanism remains unknown. It is known that SNM therapy causes direct stimulation of the anal sphincter and causes changes in rectal sensation and several central nervous system areas. The advantage of SNM therapy is the ability to do a minimally invasive temporary screening phase to assess permanent stimulation outcome. Ideal candidates for SNM therapy are not known. Several studies have described positive and negative predictive factors, but the temporary screening remains the instrument of choice. Clinical results are good and as the technique is developing, fewer complications occur. New indications for SNM include constipation and anorectal or pelvic pain.

    AB - In patients with functional bowel disorders not responding to maximal medical treatment, bowel lavage or biofeedback therapy, can nowadays be treated by sacral nerve neuromodulation (SNM). SNM therapy has evolved as a treatment for faecal incontinence and constipation. The exact working mechanism remains unknown. It is known that SNM therapy causes direct stimulation of the anal sphincter and causes changes in rectal sensation and several central nervous system areas. The advantage of SNM therapy is the ability to do a minimally invasive temporary screening phase to assess permanent stimulation outcome. Ideal candidates for SNM therapy are not known. Several studies have described positive and negative predictive factors, but the temporary screening remains the instrument of choice. Clinical results are good and as the technique is developing, fewer complications occur. New indications for SNM include constipation and anorectal or pelvic pain.

    U2 - 10.1016/j.bpg.2009.04.009

    DO - 10.1016/j.bpg.2009.04.009

    M3 - Article

    VL - 23

    SP - 545

    EP - 553

    JO - Best Practice & Research in Clinical Gastroenterology

    JF - Best Practice & Research in Clinical Gastroenterology

    SN - 1521-6918

    IS - 4

    ER -